These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 12704530)

  • 21. Advanced biological therapies for diabetic foot ulcers.
    Kirsner RS; Warriner R; Michela M; Stasik L; Freeman K
    Arch Dermatol; 2010 Aug; 146(8):857-62. PubMed ID: 20713816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical classification of bioengineered skin use and its correlation with healing of diabetic and venous ulcers.
    Saap LJ; Donohue K; Falanga V
    Dermatol Surg; 2004 Aug; 30(8):1095-100. PubMed ID: 15274699
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apligraf living skin equivalent for healing venous and chronic wounds.
    Sibbald RG
    J Cutan Med Surg; 1998 Dec; 3 Suppl 1():S1-24-8. PubMed ID: 10082604
    [No Abstract]   [Full Text] [Related]  

  • 24. Confirmatory data from EU study supports Apligraf for the treatment of neuropathic diabetic foot ulcers.
    Steinberg JS; Edmonds M; Hurley DP; King WN
    J Am Podiatr Med Assoc; 2010; 100(1):73-7. PubMed ID: 20093548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A bioengineered living cell construct activates an acute wound healing response in venous leg ulcers.
    Stone RC; Stojadinovic O; Rosa AM; Ramirez HA; Badiavas E; Blumenberg M; Tomic-Canic M
    Sci Transl Med; 2017 Jan; 9(371):. PubMed ID: 28053158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparing the efficacies of alginate, foam, hydrocolloid, hydrofiber, and hydrogel dressings in the management of diabetic foot ulcers and venous leg ulcers: a systematic review and meta-analysis examining how to dress for success.
    Saco M; Howe N; Nathoo R; Cherpelis B
    Dermatol Online J; 2016 Aug; 22(8):. PubMed ID: 27617934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Wound healing in venous ulcers; mechanisms, approach and modern developments].
    Gibbs S; van den Hoogenband HM; de Boer EM
    Ned Tijdschr Geneeskd; 2007 Mar; 151(11):635-40. PubMed ID: 17441566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of Apligraf in the treatment of venous leg ulcers.
    Dolynchuk K; Hull P; Guenther L; Sibbald RG; Brassard A; Cooling M; Delorme L; Gulliver W; Bourassa DH; Ho V; Kunimoto B; Overholt T; Papp K; Tousignant J
    Ostomy Wound Manage; 1999 Jan; 45(1):34-43. PubMed ID: 10085970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apligraf in the treatment of neuropathic diabetic foot ulcers.
    Edmonds M;
    Int J Low Extrem Wounds; 2009 Mar; 8(1):11-8. PubMed ID: 19189997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical efficacy and mechanism of bilayered living human skin equivalent (HSE) in treatment of diabetic foot ulcers.
    Brem H; Young J; Tomic-Canic M; Isaacs C; Ehrlich HP
    Surg Technol Int; 2003; 11():23-31. PubMed ID: 12931279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The cost effectiveness of Apligraf treatment of diabetic foot ulcers.
    Redekop WK; McDonnell J; Verboom P; Lovas K; Kalo Z
    Pharmacoeconomics; 2003; 21(16):1171-83. PubMed ID: 14594438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apligraf--a living human skin equivalent for the treatment of chronic wounds.
    Streit M; Braathen LR
    Int J Artif Organs; 2000 Dec; 23(12):831-3. PubMed ID: 11197742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Usage of an Extracellular, Collagen-rich Matrix: A Case Series.
    AbouIssa A; Mari W; Simman R
    Wounds; 2015 Nov; 27(11):313-8. PubMed ID: 26574754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Special segment: soft tissue matrices--Apligraf bilayered skin substitute to augment healing of chronic wounds in diabetic patients.
    DeCarbo WT
    Foot Ankle Spec; 2009 Dec; 2(6):299-302. PubMed ID: 20400430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of ulcers with Apligraf].
    Krankenpfl J; 2002; 40(1-2):32-3. PubMed ID: 12035412
    [No Abstract]   [Full Text] [Related]  

  • 36. Up-to-date role of the dehydrated human amnion/chorion membrane (AMNIOFIX) for wound healing.
    Joshi CJ; Hassan A; Carabano M; Galiano RD
    Expert Opin Biol Ther; 2020 Oct; 20(10):1125-1131. PubMed ID: 32580594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of subatmospheric (VAC) therapy to improve bioengineered tissue grafting in diabetic foot wounds.
    Espensen EH; Nixon BP; Lavery LA; Armstrong DG
    J Am Podiatr Med Assoc; 2002; 92(7):395-7. PubMed ID: 12122126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New treatments in ulcer healing and wound infection.
    Edmonds M; Bates M; Doxford M; Gough A; Foster A
    Diabetes Metab Res Rev; 2000; 16 Suppl 1():S51-4. PubMed ID: 11054889
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Stimulation of wound healing with thrombocyte growth factors in treatment of chronic unhealed wounds].
    Flesch I; Köveker G; Tolksdorf-Kremmer A; Coerper S; Becker HD
    Handchir Mikrochir Plast Chir; 1994 May; 26(3):160-4. PubMed ID: 8050747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Skin Structure-Function Relationships and the Wound Healing Response to Intrinsic Aging.
    Blair MJ; Jones JD; Woessner AE; Quinn KP
    Adv Wound Care (New Rochelle); 2020 Mar; 9(3):127-143. PubMed ID: 31993254
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.